Agency / Source: Randox Laboratories Ltd

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Randox Laboratories Ltd Unveils New Liquid Quality Control - 'Randox Acusera' - The Randox Acusera range of quality control sera is set to expand with the introduction of our new liquid ready to use QC
Randox Laboratories Ltd Unveils New Liquid Quality Control - 'Randox Acusera'

 

PRZOOM - /newswire/ - Crumlin, Antrim, United Kingdom, 2010/02/11 - The Randox Acusera range of quality control sera is set to expand with the introduction of our new liquid ready to use QC.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Liquid controls eliminate the need for reconstitution minimising the risk of human error saving labs both time and money in the process.

As always with Randox the new range guarantees the same great performance and high quality as our existing controls. In fact Randox controls are well known to be of the highest quality and the most accurate, stable and consistent controls on the market.

Liquid stable controls will be available for:

• Clinical Chemistry
• Immunoassay
• Cardiac
• Blood Gas
• Urinalysis.

Unreliable performance can result in the misdiagnosis of patients and cause delays in treatment, the use of internal quality controls is therefore important not only in detecting errors within the lab but in providing patients with reliable results and the best possible care.

Randox can also provide customised quality control materials tailor made to fit customer specifications.

In addition to our extensive range of quality control materials Randox provide 24/7 an internet driven peer group reporting system and RIQAS, an external quality assurance scheme providing customers with 15 EQA programmes.

About Randox

• Randox (randox.com) is an international diagnostic solutions company, headquartered in the UK with 25 offices worldwide.
• Randox is a market leader in developing, manufacturing and marketing clinical diagnostic products including the revolutionary Biochip Array Technology, clinical chemistry analysers and reagents, quality controls and EQA as well as a complete life science range.
• Randox provides innovative products to over 30,000 customers worldwide ranging from hospitals and research laboratories to veterinary laboratories, pharmaceutical companies and crime labs.
• Re-invests significantly into Research and Development.
• 5 x Winners of the Queen’s Award for Enterprise.
- Invest NI Innovator of the Year 2009
- Manufacturing Excellence Award 2009 for Product Innovation
• Randox is revolutionising healthcare through continuously improving diagnostic solutions.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Randox Laboratories Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Randox Laboratories Ltd Unveils New Liquid Quality Control - 'Randox Acusera'

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Chris Henry - Randox.com 
+44(0)28 9442 2413 marketing[.]randox.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Randox Laboratories Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Press Releases From Randox Laboratories Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Global Opioids Drugs Market is Projected to Grow At a CAGR of 2.52% by 2027 Reports Inkwood Research
Global Bio-Based Chemicals Market Projected to Grow At a CAGR of 16.67% by 2027 Finds Inkwood Research
The Global Animal Nutrition Market Projected to Grow At a CAGR of 5.94% by 2027 Finds Inkwood Research
FDA Approves Genentech’s Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-small Cell Lung Cancer
BTG to Invest in Chinese Medical Isotope Diagnosis and Treatment Company Chengdu New Radiomedicine Technology
Genentech Announces Positive Results for First Global Phase III Study Investigating One-dose XOFLUZA (Baloxavir Marboxil) in Children With the Flu
Debiopharm and Ipsen Extend Their Strategic Decapeptyl® (triptorelin) Partnership for Another 15 Years
GE Healthcare and World Courier Collaborate to Drive Commercialization of Cell and Gene Therapies
Nektium Pharma Commended by Frost & Sullivan for Introducing Zynamite® - A Novel Natural Extract with Ergogenic and Nootropic Properties
Trial Finds Patients Receiving CroFab® Antivenom Less Likely To Use Opioids for Pain Control

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
.



PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  BizJobs.com

Visit  Life Services Alternatives







 
  ©2019 PRZOOM - Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today